| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 Feb 2025 | 1 Feb 2025 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2025 inter alia to consider and approve the unaudited (Standalone & Consolidated) Financial results of the Company for the Quarter and Nine months ended December 31 2024 and other business matters. Please take note that the Board of Directors of the Company in their meeting held today i.e. February 9, 2025, approved the following matters: 1. Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2024 2. Appointment of Company Secretary and Compliance Officer 3. Approval of Rainbow Childrens Medicare Limited - Employee Stock Option Scheme 2025 4. Authorisation for determining materiality of an event or information under Regulation 30 of Listing Regulations Intimation regarding appointment of Company Secretary and Compliance Officer of the Company. Please take note that the Board of Directors of the Company in their meeting held today i.e. February 9, 2025, approved the following matters: 1. Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2024 2. Appointment of Company Secretary and Compliance Officer 3. Approval of Rainbow Childrens Medicare Limited - Employee Stock Option Scheme 2025 4. Authorisation for determining materiality of an event or information under Regulation 30 of Listing Regulations. (As Per BSE Announcement Dated on 09.02.2025) | ||
| Board Meeting | 27 Oct 2024 | 21 Oct 2024 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2024 inter alia to consider and approve unaudited (Standalone & Consolidated) Financial results of the Company for the Quarter and Half Year ended September 30 2024 Results for the Quarter and Half year ended September 30, 2024 (As Per BSE Announcement Dated on 27.10.2024) | ||
| Board Meeting | 13 Aug 2024 | 5 Aug 2024 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the unaudited (Standalone & Consolidated) Financial results of the Company for the Quarter ended June 30 2024 Un-Audited Financial Results for the quarter ended June 30, 2024 Outcome of Board Meeting held on August 13, 2024 (As per BSE Announcement Dated on 13/08/2024) | ||
| Board Meeting | 19 May 2024 | 12 May 2024 |
| Rainbow Childrens Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2024 inter alia to consider and approve the Audited (Standalone & Consolidated) Financial Results for the period ended March 31 2024 and to consider recommending Final Dividend if any. Recommendation of Final dividend of Rs. 3 per Equity Share for the Financial Year ended March 31, 2024 (As Per BSE Announcement Dated on 19.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
